Bulletin
Investor Alert

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

80.90

Change

+0.01 +0.01%

Volume

Volume 40,776

Feb 21, 2020, 5:22 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204510994/composite

Previous close

$ 82.77

$ 80.89

Change

-1.88 -2.27%

Day low

Day high

$80.38

$82.74

Open
Open: 82.28

52 week low

52 week high

$71.84

$96.79

Open

Market cap

$17.54B

Average volume

1.63M

P/E ratio

39.44

Rev. per Employee

$1.38M

EPS

2.05

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte stock price target raised to $116 from $111 at Instinet

    11:47 a.m. Feb. 19, 2020

    - Tomi Kilgore

  2. Incyte Climbs After Reporting a ‘Solid Quarter and Guidance’

    9:01 a.m. Feb. 13, 2020

    - Barron's Online

  3. Eli Lilly Reports Earnings Tomorrow. Here’s What to Expect.

    8:01 a.m. Jan. 29, 2020

    - Barron's Online

  4. Incyte stock price target cut to $74 from $85 at BMO Research

    10:43 a.m. Jan. 3, 2020

    - Tomi Kilgore

  5. Incyte stock slammed after study fails to hit goal

    4:40 p.m. Jan. 2, 2020

    - Jeremy C. Owens

  6. The 3 Best-Performing Health Care Stocks of 2019 So Far

    7:30 a.m. Nov. 28, 2019

    - Barron's Online

  7. Incyte shares up 1.2% premarket

    6:05 a.m. Oct. 16, 2019

    - Ciara Linnane

  8. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. Incyte (INCY) Gets a Buy Rating from Oppenheimer

    9:10 p.m. Feb. 19, 2020

    - SmarterAnalyst

  2. Incyte A Buy On 2020 Guidance And Possible Drug Approvals

    3:48 p.m. Feb. 19, 2020

    - Seeking Alpha

  3. Mizuho Securities Maintains Their Hold Rating on Incyte (INCY)

    10:35 a.m. Feb. 19, 2020

    - SmarterAnalyst

  4. Cowen & Co. Reaffirms Their Buy Rating on Incyte (INCY)

    9:41 a.m. Feb. 19, 2020

    - SmarterAnalyst

  5. Frank Sands' Firm Sells 4 Stocks in 4th Quarter

    4:22 p.m. Feb. 18, 2020

    - GuruFocus.com

  6. Stock Market News for Feb 14, 2020

    9:53 a.m. Feb. 14, 2020

    - Zacks.com

  7. Oppenheimer Sticks to Their Buy Rating for Incyte (INCY)

    7:25 p.m. Feb. 13, 2020

    - SmarterAnalyst

  8. 10-K: INCYTE CORP

    4:24 p.m. Feb. 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Incyte (INCY) Receives a Buy from Cowen & Co.

    8:19 a.m. Feb. 13, 2020

    - SmarterAnalyst

  10. Mizuho Securities Maintains Their Hold Rating on Incyte (INCY)

    8:19 a.m. Feb. 13, 2020

    - SmarterAnalyst

  11. Incyte +2% premarket on Q4 beat

    7:50 a.m. Feb. 13, 2020

    - Seeking Alpha

  12. Incyte Q4 2019 Earnings Preview

    5:30 p.m. Feb. 12, 2020

    - Seeking Alpha

  13. Notable earnings before Thursday's open

    5:30 p.m. Feb. 12, 2020

    - Seeking Alpha

  14. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Thalassemia Market to Set Spectacular Growth 2020 to 2027

    1:50 a.m. Feb. 18, 2020

    - Global QYResearch

  2. Nasdaq 100 Movers: NTAP, AMAT

    10:47 a.m. Feb. 13, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.